Pandemic Influenza Vaccine Market 2027 By Type, Dosage Form, Distribution Channel | The Insight Partners

Pandemic Influenza Vaccine Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Trivalent Flu Vaccines, Quadrivalent Flu Vaccines); Dosage Form (Nasal Spray, Intradermal Shot); Distribution Channel (Hospitals, Clinics, Others)

Report Code: TIPRE00017478 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Influenza is an acute respiratory illness that affects the upper or lower respiratory tract and is caused by influenza virus type A or B. An influenza shot is a flu vaccine that protect against the three or four influenza viruses. Influenza circulates continuously, causing seasonal epidemics in temperate regions. Immunization is the major public health measure for the prevention of influenza virus infection.

MARKET DYNAMICS

The pandemic influenza vaccine market is driving due to increasing prevalence of influenza, and increasing compliance with the vaccine worldwide. However, complexity associated with the development of influenza vaccine is expected to hamper the growth of the global pandemic influenza vaccine market. Moreover, increasing research and development activities is anticipated to drive demand the growth of the market.

MARKET SCOPE

The "Pandemic Influenza Vaccine Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pandemic influenza vaccine market with detailed market segmentation by type, dosage form and distribution channel. The pandemic influenza vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pandemic influenza vaccine market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The pandemic influenza vaccine market is segmented based on type, dosage form and distribution channel. Based on type, the market is segmented into trivalent flu vaccines, and quadrivalent flu vaccines. Based on dosage form, the market is segmented into nasal spray, and intradermal shot. Based on distribution channel, the market is segmented into hospitals, clinics, others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pandemic influenza vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pandemic influenza vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pandemic influenza vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely, North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social, and technological factors effecting the pandemic influenza vaccine market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the pandemic influenza vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pandemic influenza vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for Pandemic Influenza Vaccine market in the global market. Below mentioned is the list of few companies engaged in the Pandemic Influenza Vaccine market.
The report also includes the profiles of key players in pandemic influenza vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Sanofi
  •   AstraZeneca
  •   Seqirus
  •   Abbott
  •   GlaxoSmithKline Plc
  •   Serum Institute of India Pvt. Ltd.
  •   Zydus Cadila
  •   BiondVax Pharmaceuticals Ltd.
  •   Sinovac Biotech Ltd.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pandemic Influenza Vaccine Market - By Type
1.3.2 Pandemic Influenza Vaccine Market - By Dosage Form
1.3.3 Pandemic Influenza Vaccine Market - By Distribution Channel
1.3.4 Pandemic Influenza Vaccine Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PANDEMIC INFLUENZA VACCINE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PANDEMIC INFLUENZA VACCINE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PANDEMIC INFLUENZA VACCINE MARKET - GLOBAL MARKET ANALYSIS
6.1. PANDEMIC INFLUENZA VACCINE - GLOBAL MARKET OVERVIEW
6.2. PANDEMIC INFLUENZA VACCINE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. PANDEMIC INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. TRIVALENT FLU VACCINES
7.3.1. Overview
7.3.2. Trivalent Flu Vaccines Market Forecast and Analysis
7.4. QUADRIVALENT FLU VACCINES
7.4.1. Overview
7.4.2. Quadrivalent Flu Vaccines Market Forecast and Analysis
8. PANDEMIC INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - DOSAGE FORM
8.1. OVERVIEW
8.2. DOSAGE FORM MARKET FORECASTS AND ANALYSIS
8.3. NASAL SPRAY
8.3.1. Overview
8.3.2. Nasal Spray Market Forecast and Analysis
8.4. INTRADERMAL SHOT
8.4.1. Overview
8.4.2. Intradermal Shot Market Forecast and Analysis
9. PANDEMIC INFLUENZA VACCINE MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. OTHERS
9.5.1. Overview
9.5.2. Others Market Forecast and Analysis
10. PANDEMIC INFLUENZA VACCINE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Pandemic Influenza Vaccine Market Overview
10.1.2 North America Pandemic Influenza Vaccine Market Forecasts and Analysis
10.1.3 North America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Type
10.1.4 North America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
10.1.5 North America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Countries
10.1.6.1 United States Pandemic Influenza Vaccine Market
10.1.6.1.1 United States Pandemic Influenza Vaccine Market by Type
10.1.6.1.2 United States Pandemic Influenza Vaccine Market by Dosage Form
10.1.6.1.3 United States Pandemic Influenza Vaccine Market by Distribution Channel
10.1.6.2 Canada Pandemic Influenza Vaccine Market
10.1.6.2.1 Canada Pandemic Influenza Vaccine Market by Type
10.1.6.2.2 Canada Pandemic Influenza Vaccine Market by Dosage Form
10.1.6.2.3 Canada Pandemic Influenza Vaccine Market by Distribution Channel
10.1.6.3 Mexico Pandemic Influenza Vaccine Market
10.1.6.3.1 Mexico Pandemic Influenza Vaccine Market by Type
10.1.6.3.2 Mexico Pandemic Influenza Vaccine Market by Dosage Form
10.1.6.3.3 Mexico Pandemic Influenza Vaccine Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Pandemic Influenza Vaccine Market Overview
10.2.2 Europe Pandemic Influenza Vaccine Market Forecasts and Analysis
10.2.3 Europe Pandemic Influenza Vaccine Market Forecasts and Analysis - By Type
10.2.4 Europe Pandemic Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
10.2.5 Europe Pandemic Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Pandemic Influenza Vaccine Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Pandemic Influenza Vaccine Market
10.2.6.1.1 Germany Pandemic Influenza Vaccine Market by Type
10.2.6.1.2 Germany Pandemic Influenza Vaccine Market by Dosage Form
10.2.6.1.3 Germany Pandemic Influenza Vaccine Market by Distribution Channel
10.2.6.2 France Pandemic Influenza Vaccine Market
10.2.6.2.1 France Pandemic Influenza Vaccine Market by Type
10.2.6.2.2 France Pandemic Influenza Vaccine Market by Dosage Form
10.2.6.2.3 France Pandemic Influenza Vaccine Market by Distribution Channel
10.2.6.3 Italy Pandemic Influenza Vaccine Market
10.2.6.3.1 Italy Pandemic Influenza Vaccine Market by Type
10.2.6.3.2 Italy Pandemic Influenza Vaccine Market by Dosage Form
10.2.6.3.3 Italy Pandemic Influenza Vaccine Market by Distribution Channel
10.2.6.4 Spain Pandemic Influenza Vaccine Market
10.2.6.4.1 Spain Pandemic Influenza Vaccine Market by Type
10.2.6.4.2 Spain Pandemic Influenza Vaccine Market by Dosage Form
10.2.6.4.3 Spain Pandemic Influenza Vaccine Market by Distribution Channel
10.2.6.5 United Kingdom Pandemic Influenza Vaccine Market
10.2.6.5.1 United Kingdom Pandemic Influenza Vaccine Market by Type
10.2.6.5.2 United Kingdom Pandemic Influenza Vaccine Market by Dosage Form
10.2.6.5.3 United Kingdom Pandemic Influenza Vaccine Market by Distribution Channel
10.2.6.6 Rest of Europe Pandemic Influenza Vaccine Market
10.2.6.6.1 Rest of Europe Pandemic Influenza Vaccine Market by Type
10.2.6.6.2 Rest of Europe Pandemic Influenza Vaccine Market by Dosage Form
10.2.6.6.3 Rest of Europe Pandemic Influenza Vaccine Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Pandemic Influenza Vaccine Market Overview
10.3.2 Asia-Pacific Pandemic Influenza Vaccine Market Forecasts and Analysis
10.3.3 Asia-Pacific Pandemic Influenza Vaccine Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Pandemic Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
10.3.5 Asia-Pacific Pandemic Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Pandemic Influenza Vaccine Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Pandemic Influenza Vaccine Market
10.3.6.1.1 Australia Pandemic Influenza Vaccine Market by Type
10.3.6.1.2 Australia Pandemic Influenza Vaccine Market by Dosage Form
10.3.6.1.3 Australia Pandemic Influenza Vaccine Market by Distribution Channel
10.3.6.2 China Pandemic Influenza Vaccine Market
10.3.6.2.1 China Pandemic Influenza Vaccine Market by Type
10.3.6.2.2 China Pandemic Influenza Vaccine Market by Dosage Form
10.3.6.2.3 China Pandemic Influenza Vaccine Market by Distribution Channel
10.3.6.3 India Pandemic Influenza Vaccine Market
10.3.6.3.1 India Pandemic Influenza Vaccine Market by Type
10.3.6.3.2 India Pandemic Influenza Vaccine Market by Dosage Form
10.3.6.3.3 India Pandemic Influenza Vaccine Market by Distribution Channel
10.3.6.4 Japan Pandemic Influenza Vaccine Market
10.3.6.4.1 Japan Pandemic Influenza Vaccine Market by Type
10.3.6.4.2 Japan Pandemic Influenza Vaccine Market by Dosage Form
10.3.6.4.3 Japan Pandemic Influenza Vaccine Market by Distribution Channel
10.3.6.5 South Korea Pandemic Influenza Vaccine Market
10.3.6.5.1 South Korea Pandemic Influenza Vaccine Market by Type
10.3.6.5.2 South Korea Pandemic Influenza Vaccine Market by Dosage Form
10.3.6.5.3 South Korea Pandemic Influenza Vaccine Market by Distribution Channel
10.3.6.6 Rest of Asia-Pacific Pandemic Influenza Vaccine Market
10.3.6.6.1 Rest of Asia-Pacific Pandemic Influenza Vaccine Market by Type
10.3.6.6.2 Rest of Asia-Pacific Pandemic Influenza Vaccine Market by Dosage Form
10.3.6.6.3 Rest of Asia-Pacific Pandemic Influenza Vaccine Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Pandemic Influenza Vaccine Market Overview
10.4.2 Middle East and Africa Pandemic Influenza Vaccine Market Forecasts and Analysis
10.4.3 Middle East and Africa Pandemic Influenza Vaccine Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Pandemic Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
10.4.5 Middle East and Africa Pandemic Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Pandemic Influenza Vaccine Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Pandemic Influenza Vaccine Market
10.4.6.1.1 South Africa Pandemic Influenza Vaccine Market by Type
10.4.6.1.2 South Africa Pandemic Influenza Vaccine Market by Dosage Form
10.4.6.1.3 South Africa Pandemic Influenza Vaccine Market by Distribution Channel
10.4.6.2 Saudi Arabia Pandemic Influenza Vaccine Market
10.4.6.2.1 Saudi Arabia Pandemic Influenza Vaccine Market by Type
10.4.6.2.2 Saudi Arabia Pandemic Influenza Vaccine Market by Dosage Form
10.4.6.2.3 Saudi Arabia Pandemic Influenza Vaccine Market by Distribution Channel
10.4.6.3 U.A.E Pandemic Influenza Vaccine Market
10.4.6.3.1 U.A.E Pandemic Influenza Vaccine Market by Type
10.4.6.3.2 U.A.E Pandemic Influenza Vaccine Market by Dosage Form
10.4.6.3.3 U.A.E Pandemic Influenza Vaccine Market by Distribution Channel
10.4.6.4 Rest of Middle East and Africa Pandemic Influenza Vaccine Market
10.4.6.4.1 Rest of Middle East and Africa Pandemic Influenza Vaccine Market by Type
10.4.6.4.2 Rest of Middle East and Africa Pandemic Influenza Vaccine Market by Dosage Form
10.4.6.4.3 Rest of Middle East and Africa Pandemic Influenza Vaccine Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Pandemic Influenza Vaccine Market Overview
10.5.2 South and Central America Pandemic Influenza Vaccine Market Forecasts and Analysis
10.5.3 South and Central America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Type
10.5.4 South and Central America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Dosage Form
10.5.5 South and Central America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Pandemic Influenza Vaccine Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Pandemic Influenza Vaccine Market
10.5.6.1.1 Brazil Pandemic Influenza Vaccine Market by Type
10.5.6.1.2 Brazil Pandemic Influenza Vaccine Market by Dosage Form
10.5.6.1.3 Brazil Pandemic Influenza Vaccine Market by Distribution Channel
10.5.6.2 Argentina Pandemic Influenza Vaccine Market
10.5.6.2.1 Argentina Pandemic Influenza Vaccine Market by Type
10.5.6.2.2 Argentina Pandemic Influenza Vaccine Market by Dosage Form
10.5.6.2.3 Argentina Pandemic Influenza Vaccine Market by Distribution Channel
10.5.6.3 Rest of South and Central America Pandemic Influenza Vaccine Market
10.5.6.3.1 Rest of South and Central America Pandemic Influenza Vaccine Market by Type
10.5.6.3.2 Rest of South and Central America Pandemic Influenza Vaccine Market by Dosage Form
10.5.6.3.3 Rest of South and Central America Pandemic Influenza Vaccine Market by Distribution Channel
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PANDEMIC INFLUENZA VACCINE MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. PANDEMIC INFLUENZA VACCINE MARKET, KEY COMPANY PROFILES
13.1. SANOFI
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ASTRAZENECA
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. SEQIRUS
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. ABBOTT
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GLAXOSMITHKLINE PLC
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. SERUM INSTITUTE OF INDIA PVT. LTD.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. ZYDUS CADILA
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. BIONDVAX PHARMACEUTICALS LTD.
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. SINOVAC BIOTECH LTD.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERM
The List of Companies

1. Sanofi
2. AstraZeneca
3. Seqirus
4. Abbott
5. GlaxoSmithKline Plc
6. Serum Institute of India Pvt. Ltd.
7. Zydus Cadila
8. BiondVax Pharmaceuticals Ltd.
9. Sinovac Biotech Ltd.
TIPRE00017478
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking